Document is current
Any future updates will be listed below
-
Authors
Padilla, Frederic https://orcid.org/0000-0003-2452-9497
Foley, Jessica
Timbie, Kelsie
Bullock, Timothy N J https://orcid.org/0000-0001-6141-3261
Sheybani, Natasha D https://orcid.org/0000-0002-1137-058X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03237572 at ClinicalTrials.govnct04796220 at ClinicalTrials.govDocuments that mention this clinical trial
Guidelines for immunological analyses following focused ultrasound treatment
https://doi.org/10.1136/jitc-2023-007455
Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity
https://doi.org/10.1136/jitc-2020-001008
nct04116320 at ClinicalTrials.govDocuments that mention this clinical trial
Guidelines for immunological analyses following focused ultrasound treatment
https://doi.org/10.1136/jitc-2023-007455
nct04123535 at ClinicalTrials.govDocuments that mention this clinical trial
Guidelines for immunological analyses following focused ultrasound treatment
https://doi.org/10.1136/jitc-2023-007455
Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity
https://doi.org/10.1136/jitc-2020-001008
nct04021420 at ClinicalTrials.govDocuments that mention this clinical trial
Guidelines for immunological analyses following focused ultrasound treatment
https://doi.org/10.1136/jitc-2023-007455
Documents that mention this clinical trial
Guidelines for immunological analyses following focused ultrasound treatment
https://doi.org/10.1136/jitc-2023-007455
- License Information
